Baxter International Inc (BAX)
32.99
+0.36
(+1.10%)
USD |
NYSE |
Nov 21, 16:00
32.99
0.00 (0.00%)
Pre-Market: 07:00
Baxter International Revenue (TTM): 17.28B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 17.28B |
| June 30, 2024 | 17.18B |
| March 31, 2024 | 17.08B |
| December 31, 2023 | 17.00B |
| September 30, 2023 | 13.56B |
| June 30, 2023 | 14.57B |
| March 31, 2023 | 14.46B |
| December 31, 2022 | 14.66B |
| September 30, 2022 | 13.79B |
| June 30, 2022 | 13.40B |
| March 31, 2022 | 12.91B |
| December 31, 2021 | 12.15B |
| September 30, 2021 | 12.45B |
| June 30, 2021 | 12.20B |
| March 31, 2021 | 11.82B |
| December 31, 2020 | 11.67B |
| September 30, 2020 | 11.53B |
| June 30, 2020 | 11.41B |
| March 31, 2020 | 11.53B |
| December 31, 2019 | 11.36B |
| September 30, 2019 | 11.16B |
| June 30, 2019 | 11.07B |
| March 31, 2019 | 11.07B |
| December 31, 2018 | 11.11B |
| September 30, 2018 | 11.08B |
| Date | Value |
|---|---|
| June 30, 2018 | 11.02B |
| March 31, 2018 | 10.79B |
| December 31, 2017 | 10.58B |
| September 30, 2017 | 10.43B |
| June 30, 2017 | 10.28B |
| March 31, 2017 | 10.26B |
| December 31, 2016 | 10.16B |
| September 30, 2016 | 10.12B |
| June 30, 2016 | 10.05B |
| March 31, 2016 | 9.94B |
| December 31, 2015 | 9.968B |
| September 30, 2015 | 10.15B |
| June 30, 2015 | 10.38B |
| March 31, 2015 | 12.06B |
| December 31, 2014 | 13.50B |
| September 30, 2014 | 9.479B |
| June 30, 2014 | 10.48B |
| March 31, 2014 | 9.995B |
| December 31, 2013 | 9.595B |
| September 30, 2013 | 14.33B |
| June 30, 2013 | 14.09B |
| March 31, 2013 | 14.00B |
| December 31, 2012 | 13.94B |
| September 30, 2012 | 14.03B |
| June 30, 2012 | 14.03B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
11.36B
Minimum
Dec 2019
17.28B
Maximum
Sep 2024
13.60B
Average
13.16B
Median
Revenue (TTM) Benchmarks
| Boston Scientific Corp | 15.91B |
| Haemonetics Corp | 1.361B |
| Accuray Inc | 444.20M |
| Masimo Corp | 2.043B |
| Insulet Corp | 1.984B |